Journey Medical Corporation - Common Stock (DERM)
Competitors to Journey Medical Corporation - Common Stock (DERM)
Aclaris Therapeutics, Inc. ACRS -3.25%
Aclaris Therapeutics specializes in developing innovative dermatological treatments, particularly for conditions such as psoriasis and alopecia. Their strong focus on research and a robust clinical development pipeline for novel therapies position them uniquely against Journey Medical. Aclaris's ability to leverage advanced science and technology to address unmet medical needs gives them a competitive advantage in the rapidly evolving dermatology sector.
Cassiopea S.p.A. SKIN -10.14%
Cassiopea is a biopharmaceutical company that specializes in developing innovative dermatological products. They compete with Journey Medical by focusing on cutting-edge research and development for new dermatology therapies, specifically targeting conditions like acne and psoriasis. Their strong pipeline and active engagement in the dermatology field provide them with a competitive edge in introducing novel treatments that can outperform existing products in effectiveness and safety.
Dermatology & Skin Cancer Center
Dermatology & Skin Cancer Center focuses on providing specialized dermatological services and treatments that compete directly with Journey Medical's offerings. They have a strong local presence and established relationships with patients and healthcare providers, which allows them to attract a loyal customer base. Their personalized patient care and a broad range of services cater to various dermatological needs, creating stiff competition in the market.
Eagle Pharmaceuticals, Inc. EGRX +0.00
Eagle Pharmaceuticals develops and commercializes injectable and oral therapeutics. While they primarily focus on other therapeutic areas, they also have a growing dermatology division that competes with Journey Medical. Their competitive advantage lies in their efficient drug development process and established distribution networks, which allow them to deliver products at competitive prices and with greater accessibility in the market.
Hugel, Inc.
Hugel, Inc. is a biotechnology company focusing on aesthetics and dermatology sectors; they provide various products that compete with Journey Medical's offerings. They have a significant presence in both domestic and international markets, bolstered by their strong research capabilities and an extensive portfolio of aesthetic products, thus enhancing their competitive position against Journey Medical.